Cargando…
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
To treat hypertension, combining two or more antihypertensive drugs from different classes is often necessary. β-Blockers and renin–angiotensin–aldosterone system inhibitors, when combined, have been deemed ‘less effective’ based on partially overlapping mechanisms of action and limited evidence. Re...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548499/ https://www.ncbi.nlm.nih.gov/pubmed/28509722 http://dx.doi.org/10.1097/HJH.0000000000001412 |